Profit And Price Declaration Requirements Mar Otherwise Workable Vietnam Medtech Regulation

Vietnam’s medtech industry breathed more easily when the new decree, 98/2021, became the regulatory instrument for the sector on 1 January. While its practical approach to industry’s needs was welcomed, new price and profit declaration demands will be harder for companies to swallow.

Alamy

After several years of faltering progress on the release of new regulatory texts, subsequent delays and rethinks, Vietnam has finally issued a decree on regulating the medtech sector that has met with industry’s approval – to large extent, at least.

More from Asia

More from Geography